Latest Market News

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

Reef Casino Trust’s takeover bid by Iris Cairns Property faces a regulatory hurdle as Queensland’s Office of Liquor and Gaming Regulation delays suitability investigations, pushing the offer period beyond March 2026.

Tartana Minerals has secured a $1.275 million placement priced at a 17% premium, including significant director participation pending shareholder approval. The capital raise aims to strengthen working capital and retire convertible notes, supporting advancement of its Chillagoe assets.

Narryer Metals has outlined a substantial Exploration Target for its Rocky Gully Project in Western Australia, highlighting promising grades of scandium, rare earth elements, gallium, and potential titanium co-products. The company is gearing up for a new drilling campaign aimed at defining a maiden resource.

VRX Silica Limited has raised $2.1 million through a share placement to fund critical pre-construction activities at its Arrowsmith North Silica Sand Project, aiming to strengthen its position in high-quality silica sand markets.

Element 25 Limited is making significant strides in expanding its Butcherbird Manganese Mine, securing $60 million in funding and advancing critical engineering and contract milestones to boost manganese concentrate production to 1.1 million tonnes per annum.

Stealth Group Holdings has secured $19.5 million through a share placement to strengthen its balance sheet, reduce debt, and fund the integration of Hardware and Building Traders (HBT) alongside its wholesale distribution expansion.

Fulcrum Lithium reports encouraging initial metallurgical results from its Alkali Flats project in Nevada, showing up to 91% lithium recovery at moderate conditions, setting the stage for further exploration and resource definition.

IVE Group Limited reported a robust FY25 with significant profit growth and margin expansion, driven by strategic logistics expansions and the rising Lasoo e-commerce platform. Despite a softer FY26 start, the company maintains steady dividends and growth ambitions.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.

Centuria Capital Group has expanded its agriculture portfolio by acquiring Australia’s largest hydroponic glasshouse facility in South Australia for $168 million, boosting its agriculture assets under management by 25%.

Zeotech Limited’s AusPozz™ has been independently validated by BG&E as a high-performance, low-carbon supplementary cementitious material, showing remarkable strength gains and durability benefits in concrete applications.